Refund of Overpayments Made by Patients :
HB 1513 creates new statutory requirements for refunds of patient overpayments in Florida. It requires a licensee, health care practitioner, billing department, management company, or group practice that bills a government-sponsored program, private health insurer, or health maintenance organization to refund any patient overpayment within 30 days after determining the overpayment occurred. The bill defines “tenders charges for reimbursement” to mean filing a reimbursement claim for services rendered to the patient, and it excludes overpayments already governed by existing insurance-related statutes.
The bill applies both to health care licensees under chapter 408 and to health care practitioners under chapter 456. It creates new sections 408.12 and 456.0625, authorizes an administrative fine for noncompliance under s. 408.813, and makes a practitioner’s failure to refund an overpayment grounds for disciplinary action under s. 456.072. The measure takes effect January 1, 2026, and is intended to strengthen patient protections and billing accountability in the health care system.
HB 1513 would add a new legal duty for health care providers and related billing entities to promptly return patient overpayments, and it would give the Agency for Health Care Administration enforcement authority through administrative fines. It also expands professional discipline exposure for practitioners by tying noncompliance to the existing grounds-for-discipline statute. The bill affects Florida’s health care licensing and disciplinary framework, as well as providers, practices, billing departments, management companies, insurers, and patients who may receive refunds.
The available context suggests generally favorable sentiment toward the bill’s consumer-protection purpose, as reflected by the fact that a companion measure passed and the House bill was laid on the table. There are no recorded committee transcripts or vote details in the provided materials, so there is no evidence of organized opposition in the record supplied. Overall, the bill appears to have been treated as a straightforward patient billing reform measure.
The main policy issue is how broadly the refund obligation reaches and how quickly providers must act once an overpayment is identified. Potential points of contention include administrative burden on practices and billing entities, the scope of entities covered by the bill, and whether existing insurance refund statutes already address some of the same situations. The bill also creates enforcement consequences—fines and professional discipline—which could be viewed as necessary consumer protection by supporters and as a compliance risk by providers.